Trial Profile
A clinical, histological and histochemical examination fo injection site reactions after subcutaneous injection of Fuzeon [enfuvirtide] during treatment of HIV-1 infection
Status:
Active, no longer recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 31 Mar 2006
Price :
$35
*
At a glance
- Drugs Enfuvirtide (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- Sponsors Trimeris
- 31 Mar 2006 New trial record.